Ver Investigador - - Prisma - Unidad de Bibliometría

Eduardo Rios Herranz

Profesor Asociado CIS
erios@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin grupo

Investiga en

Tipo Año Título Fuente
Artículo2024 CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma FRONTIERS IN IMMUNOLOGY
Artículo2024 Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC) EClinicalMedicine
Artículo2023 Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma Journal of Oncology Pharmacy Practice
Artículo2023 Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study LEUKEMIA & LYMPHOMA
Artículo2022 Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis CLINICAL CANCER RESEARCH
Artículo2021 Case-control analysis of the impact of anemia on quality of life in patients with cancer: a QCA study analysis CANCERS
Artículo2021 Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial JOURNAL FOR IMMUNOTHERAPY OF CANCER
Artículo2021 Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2020 A case-control analysis of the impact of venous thromboembolic disease on quality of life of patients with cancer: Quality of life in cancer (QCA) study CANCERS
Artículo2020 Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019 Calidad de vida relacionada con la salud en pacientes oncológicos con enfermedad tromboembólica venosa aguda sintomática: diseño del estudio QCA (quality of life in cancer), estudio de casos y controles Revista Española de Patología Torácica
Resumen congreso2019 Evolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunotherapy ANNALS OF ONCOLOGY
Revisión2018 Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2015 Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure TRANSFUSION
Artículo2015 Trisomy 8, a cytogenetic abnormality in myelodysplastic syndromes, is constitutional or not? PLOS ONE
Ponencia2014 Clinical utility of the collect scale to assess comorbidities in patients with chronic lymphocytic leukemia VALUE IN HEALTH
Artículo2014 Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma EUROPEAN JOURNAL OF HAEMATOLOGY
Ponencia2013 National guidelines for the management of patients with chronic lymphocytic leukemia MEDICINA CLINICA
Letter2013 Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/sezary syndrome BRITISH JOURNAL OF HAEMATOLOGY
Resumen congreso2012 Clinical prognostic factors for myelodysplastic syndromes presenting non-unfavourable cytogenetic categories according to IPSS and the new cytogenetic prognostic scoring system HAEMATOLOGICA
Artículo2011 Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia GACETA SANITARIA
Corrección2011 Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia (vol 25, pg 274, 2011) GACETA SANITARIA
Revisión2011 Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab EXPERT REVIEW OF HEMATOLOGY
Artículo2011 Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients INTERNATIONAL JOURNAL OF HEMATOLOGY
Resumen congreso2009 PO-065 Valor pronóstico de la enfermedad mínima residual previa al trasplante de progenitores hemopoyéticos en pacientes con leucemia mieloide aguda HAEMATOLOGICA
Capítulo2009 Programa de trasplante de progenitores hematopoyéticos de los HH UU Virgen del ROCÍO en 2008 Actualizaciones en trasplantes 2009
Capítulo2009 Trasplante alogénico de progenitores hemopoyéticos con acondicionamiento de intensidad reducida en pacientes con neoplasias linfoides. Nuestra experiencia Actualizaciones en trasplantes 2009
Letter2005 Pure red cell aplasia associated with chronic lymphocytic leukaemic succesfuly treated with rituximab MEDICINA CLINICA
Letter2005 Pure red cell aplasia associated with chronic lymphocytic leukaemic succesfuly treated with rituximab [2] MEDICINA CLINICA
Artículo2003 CD56 IN T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA: A MALIGNANT TRANSFORMATION OF AN EARLY MYELOID-LYMPHOID PROGENITOR? HAEMATOLOGICA
Artículo2002 THROMBOTIC THROMBOCYTOPENIC PURPURA AND BONE MARROW NECROSIS AS A COMPLICATION OF GASTRIC NEOPLASM HAEMATOLOGICA
Letter2001 Aggressive natural killer cell leukemia and presence of Epstein-Barr virus REVISTA CLINICA ESPANOLA
Letter2001 ENFERMEDAD DE HODGKIN DE COMIENZO EPITROCLEAR ANALES DE MEDICINA INTERNA
Letter2001 Primary cutaneous large B-cell lymphoma of the leg with bad evolution HAEMATOLOGICA
Artículo1999 Multiple myeloma with numerous intranuclear Russell bodies HAEMATOLOGICA
Artículo1997 Chronic lymphocytic leukemia with two cellular populations: A biphenotypic or biclonal disease ANNALS OF HEMATOLOGY
Artículo1996 Leukaemia of natural killer cell large granular lymphocyte type with HLA-DR(-)CD16(-)CD56(bright+) phenotype JOURNAL OF CLINICAL PATHOLOGY
Artículo1995 Richter syndrome: morphologic transformation with persistence of the same phenotype SANGRE
Letter1992 Aplastic anemia and cyanamide EUROPEAN JOURNAL OF HAEMATOLOGY
Letter1991 HYPEREOSINOPHILIA AND ACUTE LYMPHOCYTIC-LEUKEMIA POSTGRADUATE MEDICAL JOURNAL
Letter1991 Thrombopenia induced by low molecular weight heparin [1] MEDICINA CLINICA
Este investigador no ha dirigido/tutorizado tesis
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado